The newest version of LabVantage Solutions’ laboratory information management system software is designed to help drug manufacturers conform to FDA’s data integrity draft guidance.
LabVantage 8.3 is the newest version of LabVantage Solutions’ laboratory information management system (LIMS) software and its first good practice (GxP)-compliant solution for data integrity and auditing. The new software, released in October 2017, is designed to help drug manufacturers conform to FDA’s draft guidance, Data Integrity and Compliance with CGMP.
A new dynamic auditing feature in the company’s LIMS platform will help ensure that companies are able to meet current and proposed regulatory guidance for data management in temporary memory. New and emerging data integrity standards put forth by FDA, UK Medicines and Healthcare Products Regulatory Agency, and World Health Organization would require the capture of temporary data in electronic records. FDA’s draft guidance states that electronic data that will become part of a permanent cGMP record cannot be stored electronically in temporary memory where it could be subject to manipulation.
LabVantage’s dynamic auditing tool helps users maintain a clean and complete GxP-compliant audit trail based on a full history of analytical testing, including:
In addition to the new software, LabVantage has also expanded its inventory of laboratory execution system (LES) worksheets. The company has added new LES worksheets to its existing LES worksheets, which are based on test methods. The new worksheets are now available for: quality control batch testing, used during the testing of unknown samples; instrument certification, used to maintain and calibrate instruments; and finished product sample testing, which facilitates the review of multiple analytical tests on a single sample.
Another new tool, the chemical viewer, has also been added to the electronic laboratory notebook (ELN) and LES. With this viewer, users can upload a chemical file to a designated location or copy it into the control system. It offers an editable graphic rendering of the chemical structure defined in the file.
Other new features of LabVantage 8.3 include:
Source: LabVantage
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.